Page last updated: 2024-08-23

etomidate and ACTH Syndrome, Ectopic

etomidate has been researched along with ACTH Syndrome, Ectopic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Constantinescu, SM; Corvilain, B; Driessens, N; Furnica, RM; Lefebvre, A; Maiter, D1
Joshiraj, B; Kishore, S; Krishnan, G; Misra, M; Sharma, A; Subramaniam, R; Varma, P1
Canada, TW; Johnson, TN1

Other Studies

3 other study(ies) available for etomidate and ACTH Syndrome, Ectopic

ArticleYear
Etomidate infusion at low doses is an effective and safe treatment for severe Cushing's syndrome outside intensive care.
    European journal of endocrinology, 2020, Volume: 183, Issue:2

    Topics: ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adult; Aged; Cushing Syndrome; Dose-Response Relationship, Drug; Etomidate; Female; Hospital Units; Humans; Hydrocortisone; Intensive Care Units; Male; Middle Aged; Treatment Outcome

2020
Anesthetic management of emergent laparoscopic bilateral adrenalectomy in a patient with a life-threatening cortisol crisis.
    A & A case reports, 2015, Jan-15, Volume: 4, Issue:2

    Topics: ACTH Syndrome, Ectopic; Adrenalectomy; Adrenocorticotropic Hormone; Anesthetics; Critical Illness; Cushing Syndrome; Edema; Etomidate; Fentanyl; Humans; Hydrocortisone; Hypokalemia; Laparoscopy; Male; Middle Aged; Treatment Outcome

2015
Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:2

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Aged; Cushing Syndrome; Etomidate; Fatal Outcome; Humans; Hydrocortisone; Hypnotics and Sedatives; Injections, Intravenous; Male; Prostatic Neoplasms

2007